TerrAscend - TRSSF Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $3.19
  • Forecasted Upside: 120.36%
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$1.45
▲ +0.02 (1.40%)

This chart shows the closing price for TRSSF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New TerrAscend Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TRSSF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TRSSF

Analyst Price Target is $3.19
▲ +120.36% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for TerrAscend in the last 3 months. The average price target is $3.19, with a high forecast of $4.50 and a low forecast of $1.75. The average price target represents a 120.36% upside from the last price of $1.45.

This chart shows the closing price for TRSSF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 6 polled investment analysts is to buy stock in TerrAscend. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/2/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 0 sell ratings
12/31/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 2 hold ratings
  • 0 sell ratings
3/31/2022
  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 0 sell ratings
6/29/2022
  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 0 sell ratings
9/27/2022
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 0 sell ratings
12/26/2022
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 0 sell ratings
2/24/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
3/26/2023

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
3/17/2023Needham & Company LLCReiterated RatingBuy$1.75
2/8/2023Stifel NicolausLower TargetC$5.50 ➝ C$4.50
10/28/2022Cantor FitzgeraldLower TargetNeutral$2.85 ➝ $2.15
9/12/2022Canaccord Genuity GroupInitiated CoverageBuyC$4.25
8/15/2022CowenLower Target$9.00 ➝ $4.50
8/12/2022Stifel NicolausLower TargetC$6.00 ➝ C$5.50
8/12/2022Craig HallumDowngradeBuy ➝ Hold$7.50 ➝ $2.00
8/12/2022Needham & Company LLCLower TargetBuy$4.00 ➝ $3.00
8/12/2022Cantor FitzgeraldDowngradeOverweight ➝ Neutral
7/22/2022Seaport Res PtnReiterated RatingBuy
5/13/2022Echelon Wealth PartnersReiterated RatingHold
3/17/2022Clarus SecuritiesReiterated RatingBuy
3/17/2022Needham & Company LLCInitiated CoverageBuy$8.00
3/17/2022Cantor FitzgeraldBoost TargetOverweight$7.65 ➝ $7.90
3/16/2022Atb Cap MarketsReiterated RatingOutperform
12/8/2021Cantor FitzgeraldBoost TargetOverweight ➝ Overweight$6.70 ➝ $7.65
11/17/2021Stifel NicolausLower TargetBuyC$23.00 ➝ C$21.00
11/3/2021Cantor FitzgeraldLower TargetOverweight$8.65 ➝ $6.70
11/1/2021Stifel NicolausLower TargetBuyC$25.00 ➝ C$23.00
9/23/2021Cantor FitzgeraldLower TargetOverweight$10.50 ➝ $8.65
8/20/2021Craig HallumLower TargetTop Pick ➝ Buy$21.50 ➝ $13.50
8/20/2021CowenLower TargetOutperform$13.00 ➝ $9.00
7/27/2021Needham & Company LLCLower TargetBuy$17.75 ➝ $17.00
7/7/2021Jefferies Financial GroupInitiated CoverageBuy$17.00
4/15/2021CowenInitiated CoverageOutperform
3/24/2021Needham & Company LLCBoost TargetBuy$17.50 ➝ $17.75
3/24/2021Cantor FitzgeraldLower TargetOverweight$21.00 ➝ $16.00
2/25/2021Stifel NicolausBoost TargetBuy$12.50 ➝ $24.00
2/19/2021Clarus SecuritiesBoost TargetBuy$18.75 ➝ $20.00
2/9/2021Craig HallumBoost TargetBuy$10.50 ➝ $20.00
1/19/2021Needham & Company LLCBoost TargetBuy$11.75 ➝ $17.50
1/8/2021Cantor FitzgeraldInitiated CoverageOverweight
12/21/2020Beacon SecuritiesBoost Target$13.50
12/18/2020Needham & Company LLCBoost Target$9.50 ➝ $11.50
12/16/2020Clarus SecuritiesInitiated CoverageBuyC$12.75 ➝ C$13.50
11/2/2020Needham & Company LLCBoost TargetBuy ➝ Buy$5.50 ➝ $7.50
8/25/2020Needham & Company LLCInitiated CoverageBuy$5.50
8/7/2020Stifel NicolausBoost TargetBuy$4.75 ➝ $6.50
7/22/2020Stifel NicolausInitiated CoverageBuy
6/15/2020LADENBURG THALM/SH SHInitiated CoverageBuy
6/8/2020Craig HallumInitiated CoverageBuy
(Data available from 3/26/2018 forward)

News Sentiment Rating

0.78 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 5 very positive mentions
  • 7 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
8/28/2022
  • 1 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
9/27/2022
  • 5 very positive mentions
  • 8 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
10/27/2022
  • 5 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/26/2022
  • 4 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/26/2022
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/25/2023
  • 3 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/24/2023
  • 4 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
3/26/2023

Current Sentiment

  • 4 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
TerrAscend logo
TerrAscend Corp. produces and sells medical cannabis products. The firm owns several businesses and brands, including The Apothecarium, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections and Arise Bioscience Inc. The company was founded by Basem Hanna, Vijay Sappani and Michael Nashat on March 7, 2017 and is headquartered in Mississauga, Canada.
Read More

Today's Range

Now: $1.45
Low: $1.39
High: $1.46

50 Day Range

MA: $1.53
Low: $1.21
High: $1.81

52 Week Range

Now: $1.45
Low: $1.00
High: $6.06

Volume

366,606 shs

Average Volume

315,883 shs

Market Capitalization

$364.79 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of TerrAscend?

The following equities research analysts have issued reports on TerrAscend in the last twelve months: Canaccord Genuity Group Inc., Cantor Fitzgerald, Cowen Inc, Craig Hallum, Echelon Wealth Partners, Needham & Company LLC, Seaport Res Ptn, and Stifel Nicolaus.
View the latest analyst ratings for TRSSF.

What is the current price target for TerrAscend?

6 Wall Street analysts have set twelve-month price targets for TerrAscend in the last year. Their average twelve-month price target is $3.19, suggesting a possible upside of 120.4%. Stifel Nicolaus has the highest price target set, predicting TRSSF will reach $4.50 in the next twelve months. Needham & Company LLC has the lowest price target set, forecasting a price of $1.75 for TerrAscend in the next year.
View the latest price targets for TRSSF.

What is the current consensus analyst rating for TerrAscend?

TerrAscend currently has 3 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe TRSSF will outperform the market and that investors should add to their positions of TerrAscend.
View the latest ratings for TRSSF.

What other companies compete with TerrAscend?

How do I contact TerrAscend's investor relations team?

TerrAscend's physical mailing address is PO Box 43125, Mississauga, ON L5B. The company's listed phone number is (855) 837-7295 and its investor relations email address is [email protected] The official website for TerrAscend is www.terrascend.com. Learn More about contacing TerrAscend investor relations.